DocMeetings

The CLL Sessions

CLL

​

Europe/Madrid GMT+2

Description

​

Frontline therapy for CLL, BTK inhibitors in CLL – ibrutinib/acalabrutinib, Novel combination therapy in CLL, MRD negativity in CLL and R/R CLL, Treatment sequencing & novel therapies

Inglês

Speakers

John Gribben, Susan O'Brien, Matthew Davids, Barbara Eichhorst

Link to the Event

http://ow.ly/aFJz50AK2UX

Banner to the Event

Register your event here

Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.